Skip to main content

Day: September 1, 2020

DPW Holdings Announces Second Annual Investor Day Conference and Webcast

NEWPORT BEACH, Calif., Sept. 01, 2020 (GLOBE NEWSWIRE) — DPW Holdings, Inc. (NYSE American: DPW) a diversified holding company (“DPW” or the “Company”) will webcast its Second Annual Investor Conference on September 22, 2020, with presentations beginning at approximately 10:00 a.m. PT. The Company will provide updates on recent performance, current activities and plans for the future. The investor day will be hosted by Milton “Todd” Ault, III, DPW’s CEO and Chairman, William B. Horne, DPW’s President and Kenneth S. Cragun, DPW’s Chief Financial Officer.In addition to the hosts, the presenters will include:Jonathan Read, CEO of the Company’s global defense business, Gresham Worldwide, Inc. Amos Kohn, President and CEO of the Company’s power electronics business, Coolisys Technologies Corp. Darren Magot, CEO Ault Global, Inc., which...

Continue reading

Form 8.3 – [Honeycomb Investment Trust plc] – (HHL)

FORM 8.3PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)1.         KEY INFORMATION2.         POSITIONS OF THE PERSON MAKING THE DISCLOSUREIf there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.(a)        Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)All interests and all short positions should be disclosed.Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should...

Continue reading

Ress Life Investments AS – Company Announcement shareholder announcement

Ress Life InvestmentsHolbergsgade 14, 2 tvDK-1057 Copenhagen KDenmarkCVR nr. 33593163www.resslifeinvestments.comTo: Nasdaq CopenhagenDate: 1 September 2020Corporate Announcement 32/2020Major shareholder announcement pursuant to section 30 of the Capital Markets ActRess Life Investments A/S has received notification that Volvo Car UK Pension Scheme holds more than 5% of the share capital and voting rights in Ress Life Investments A/S.On 31 August 2020, Volvo Car UK Pension Scheme holds 7,246 shares in Ress Life Investments A/S with a total nominal value of EUR 3,623,000 corresponding to 6,95% of the total share capital and voting rights in Ress Life Investments A/S.Questions related to this announcement can be made to the company’s AIF-manager, Resscapital AB.Contact person:Gustaf Hagerudgustaf.hagerud@resscapital.comTel +46 8 545 282...

Continue reading

Form 8.3 – [RWS Holdings plc] – (CGWL) – CORRECTION

This form supersedes the one published on 28/08/2020, which contained a typographical error.FORM 8.3PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)1.         KEY INFORMATION2.         POSITIONS OF THE PERSON MAKING THE DISCLOSUREIf there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.(a)        Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)All interests and all short positions should be disclosed.Details of any open stock-settled derivative positions...

Continue reading

Medical Practice Income, Inc., a Subsidiary of USA Equities Corp. (USAQ), Announces the Early Success of QHSLab Launch in South Florida

West Palm Beach, FL, Sept. 01, 2020 (GLOBE NEWSWIRE) — Medical Practice Income (MPI), a subsidiary of USA Equities Corp. (OTC Link: USAQ), a company focused on value-based healthcare solutions and physician-directed digital medicine, is proud to announce the early success of the QHSLab launch in South Florida. Since launching the platform on June 30, 2020, 159 medical practices have provided 374 allergy patients with a QHSLab-generated allergen immunotherapy prescription, generating an estimated $664,608 in reimbursement revenue to these physicians practices.There are over 450,000 primary care physicians, including licensed nurse practitioners, in the United States. Many are reporting higher rates of fatigue and burnout due to long hours, heavy patient caseloads, and declining practice revenue from a lack of healthcare reimbursements....

Continue reading

Nabis Holdings Inc. Reports Second Quarter 2020 Financial Results

Q2 2020 top line revenue increased 73% to $4.0M from $2.3M in Q1 2020Q2 2020 Gross Margin increased 4% to 46% compared to Q1 2020 VANCOUVER, British Columbia, Sept. 01, 2020 (GLOBE NEWSWIRE) — Nabis Holdings Inc. (CSE: NAB) (OTC: NABIF) (FRA: A2PL) (“Nabis” or the “Company”) reports its financial results for the three and six-month periods ended June 30, 2020. All financial information is provided in Canadian dollars unless otherwise indicated.Results of OperationsRetail revenue for the three and six-month periods ended June 30, 2020 was $3,987,777 and $6,294,736 respectively. (2019-$nil). Cost of goods sold for the same periods was $2,144,880 and $3,475,693 (2019-$nil) and gross profit was $1,842,897 and $2,819,043 or 46.2% for the three month period and 44.8% for the six month period ended June 30, 2020 (2019-$nil).Basic and diluted...

Continue reading

CLA Advises on Sale of Miller Auto to Gilleland Enterprises

St. Cloud, Minnesota, Sept. 01, 2020 (GLOBE NEWSWIRE) — CLA (CliftonLarsonAllen LLP) announced today that it helped Miller Auto find a new owner. Started in 1932 as a small repair shop operated by John Miller, the father of selling owner Tom Miller, the automotive dealership’s operations have grown to include new models of GMC, Nissan, Buick, and Lincoln, along with a huge selection of pre-owned makes and models. Gilleland Enterprises now takes over as the new owner.About CLACLA exists to create opportunities for our clients, our people, and our communities through industry-focused wealth advisory, outsourcing, audit, tax, and consulting services. With more than 6,200 people, 120 U.S. locations and a global affiliation, we promise to know you and help you. Investment advisory services are offered through CliftonLarsonAllen Wealth...

Continue reading

DR Power Equipment Enters Battery Powered Zero-Turn Mower Market with Acquisition of Mean Green Products, LLC

SOUTH BURLINGTON, Vt., Sept. 01, 2020 (GLOBE NEWSWIRE) — DR Power Equipment, a division of Generac Holdings Inc., today announced the closing of a purchase agreement to acquire the assets of Mean Green Products, LLC, the leading battery powered, commercial grade turf care manufacturer, headquartered in Ross, Ohio.DR Power Equipment designs and manufactures a full line of professional-grade, outdoor power equipment. Mean Green Products designs and manufacturers an innovative commercial line of zero-turn and walk behind, battery powered turf care products that provide quiet, zero emissions and minimal maintenance options as compared to traditional commercial mowers. “Entering the commercial turf care category has been a target of ours for years, but we wanted to do it in an innovative and differentiated way.  The improvements in battery...

Continue reading

Medallion Advances Rare-Earth Element Process Optimization with Saskatchewan Research Council

VANCOUVER, British Columbia, Sept. 01, 2020 (GLOBE NEWSWIRE) — Medallion Resources Ltd. (TSX-V: MDL; OTCPK: MLLOF; Frankfurt: MRDN) – “Medallion” or the “Company” is pleased to announce the commencement of further rare-earth element (REE) process optimization test work at the Saskatchewan Research Council (SRC). The SRC has been a long-term research partner of Medallion, instrumental in the delivery of data for the design of Medallion’s proprietary REE-  extraction technology that utilizes the REE-rich mineral monazite. The current test work will provide additional detail on various stages in the breakdown of monazite and in the recovery of phosphate as a secondary product. Completion is anticipated within one month. The testing further develops key areas where the Medallion monazite process has advantages over the traditional process.“We...

Continue reading

Global Health Leaders Join CytoDyn’s Scientific Advisory Board

Leading experts in the fields of HIV, Oncology, Rheumatology, and NASH join together to facilitate the best approaches to utilize multiple opportunities for leronlimabVANCOUVER, Washington, Sept. 01, 2020 (GLOBE NEWSWIRE) — CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced the formation and initial members of its Scientific Advisory Board today including leading HIV, NASH, Oncology, and Rheumatological clinical experts and researchers.CytoDyn’s Scientific Advisory Board members include Dr. Gero Hütter, German hematologist, best known for the bone marrow transplant resulting in the cure of the first HIV patient; Dr. Hope S. Rugo, Professor,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.